Oncternal Therapeutics Inc (NASDAQ:ONCT)
North American company
Share Price Chart
- Chart currently unavailable -
Market Info - ONCT
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - ONCT
- Market Cap$266.270m
- SymbolNASDAQ:ONCT
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINUS68236P1075
Company Profile
Oncternal Therapeutics Inc is a clinical-stage oncology company developing first-in-class, novel therapies that target a broad spectrum of cancers with a large unmet medical need. Its product pipeline includes Cirmtuzumab, TK216, and ROR1 CAR-T.GTx Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of small molecules for treatment of cancer, including treatments for breast and prostate cancer and other medical conditions.
Latest ONCT news
Currently there for this company. Visit our news hub for other news .